Tirzepatide Dosage Chart: A Physician's Complete Guide to Dose Escalation

Tirzepatide Dosage Chart: A Physician's Complete Guide to Dose Escalation

By Dr. Onikepe Adegbola, MD PhD

When patients start tirzepatide — whether as Mounjaro for type 2 diabetes or Zepbound for weight management — the single most common question I hear is: "When do I go up on my dose?" It's a fair question. Tirzepatide uses a structured dose-escalation schedule, and getting it right matters more than most people realize.

Too fast, and you're fighting nausea for weeks. Too slow, and you're spending months at a dose that isn't doing much. Here's the full tirzepatide dosage chart, along with the clinical reasoning behind every step.

The Standard Tirzepatide Dosage Chart

Tirzepatide is available in six single-dose pen strengths. The FDA-approved escalation schedule is the same for both Mounjaro (diabetes) and Zepbound (weight loss):

Phase	Dose	Duration	Purpose
Starting	2.5 mg/week	4 weeks	GI tolerance initiation — not a therapeutic dose
Escalation 1	5 mg/week	4 weeks	First therapeutic dose; noticeable appetite reduction
Escalation 2	7.5 mg/week	4 weeks	Intermediate dose; stronger appetite and glucose control
Escalation 3	10 mg/week	4 weeks	High efficacy for most patients; common maintenance dose
Escalation 4	12.5 mg/week	4 weeks	Maximum efficacy range for weight loss
Maximum	15 mg/week	Ongoing	Highest approved dose; reserved for patients needing additional response

Why the 2.5 mg Starting Dose Isn't Really a Treatment Dose

This trips up a lot of patients. The 2.5 mg dose is an initiation dose — its primary job is to let your GI tract adjust to having GLP-1 and GIP receptor agonism on board. Some patients notice mild appetite suppression at 2.5 mg, but most don't see meaningful weight loss or glucose changes until they reach 5 mg.

Don't be discouraged if the first month feels like nothing is happening. That's by design.

How Tirzepatide Dosing Differs From Semaglutide

Patients switching from semaglutide (Ozempic or Wegovy) often ask how the tirzepatide dosage chart compares. The key difference: tirzepatide is a dual agonist, targeting both GLP-1 and GIP receptors simultaneously. Semaglutide only hits GLP-1.

In practical terms:

• Semaglutide escalation: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg (for Wegovy)
• Tirzepatide escalation: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg

The milligram numbers aren't comparable — they're different molecules with different receptor binding affinities. A patient on semaglutide 1 mg doesn't automatically start tirzepatide at a "comparable" mid-range dose. In my practice, I see patients restart at tirzepatide 2.5 mg even if they've been on higher semaglutide doses. The GI adjustment to dual agonism is a separate process.

When to Stay at a Dose vs. Escalate

The dosage chart is a ceiling, not a mandate. Not every patient needs to reach 15 mg. Here's how I approach dose decisions with my patients:

Signs You Should Stay at Your Current Dose

• You're losing 1–2% of body weight per month consistently
• Your A1c is at target (for diabetes patients)
• Appetite suppression is well-controlled without severe restriction
• Side effects are manageable or resolved

Signs It's Time to Escalate

• Weight loss has stalled for 4+ weeks despite adherence to diet and activity
• A1c remains above target
• Appetite suppression has significantly diminished
• You're tolerating the current dose well with no GI issues

Signs You Should Slow Down Escalation

• Persistent nausea, vomiting, or diarrhea lasting more than 5–7 days after a dose increase
• Inability to maintain adequate hydration or caloric intake
• Severe constipation or abdominal pain

In my practice, I see about 30% of patients who need to extend a dose step beyond the standard 4 weeks. This is perfectly fine. The SURMOUNT and SURPASS trials allowed this kind of flexibility, and outcomes were still strong.

Tirzepatide Dose and Weight Loss: What the Data Shows

The SURMOUNT-1 trial enrolled adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity. At 72 weeks:

• 5 mg dose: Average 15% body weight loss
• 10 mg dose: Average 19.5% body weight loss
• 15 mg dose: Average 20.9% body weight loss

Notice the diminishing returns between 10 mg and 15 mg — an extra 5 mg yielded only about 1.4% more weight loss on average. This is why many clinicians, myself included, find that 10 mg is the sweet spot for a large proportion of patients. Going higher only makes sense when the response at 10 mg is insufficient.

Dose-Response for Blood Sugar Control

In the SURPASS trials for type 2 diabetes, A1c reductions followed a similar pattern:

• 5 mg: A1c reduction of ~2.0%
• 10 mg: A1c reduction of ~2.2%
• 15 mg: A1c reduction of ~2.3%

Again, the jump from 5 mg to 10 mg is much larger than from 10 mg to 15 mg. For some diabetes patients, 5 mg may be sufficient maintenance.

Practical Tips for Each Dose Step

At 2.5 mg (Weeks 1–4)

Focus on building habits, not results. Start eating smaller meals, increase protein intake, and establish hydration routines. Mild nausea is common. If it's severe, talk to your prescriber about anti-nausea strategies before your dose increase.

At 5 mg (Weeks 5–8)

This is where most patients feel it. Appetite drops noticeably. The risk here is under-eating — your body still needs adequate protein (aim for 1.0–1.2 g per kg of body weight daily) to preserve muscle mass during weight loss.

At 7.5–10 mg (Weeks 9–16)

GI side effects may resurge with each increase. Constipation becomes more common at these doses. Adequate fiber and hydration are critical. Some patients benefit from a targeted motility support supplement at this stage.

At 12.5–15 mg (Weeks 17+)

You're at or near maximum efficacy. If you're not seeing adequate results at these doses with good dietary adherence, your clinician should investigate other factors — thyroid function, sleep, medication interactions, insulin resistance patterns.

Throughout every dose step, maintaining nutrition quality is as important as the medication itself. Many of my patients find that a structured Casa de Sante GLP-1 supplements regimen helps fill the nutritional gaps that come with reduced food intake.

Common Tirzepatide Dosage Questions

Can I Skip a Dose Step?

No. Skipping from 2.5 mg to 7.5 mg, for instance, dramatically increases your risk of severe nausea and vomiting. The stepwise approach exists because clinical trials showed it reduces GI side effects by 40–60% compared to starting at higher doses directly.

What If I Miss a Dose?

If it's been less than 4 days (96 hours) since your missed dose, take it as soon as you remember. If more than 4 days have passed, skip that dose and resume your regular schedule. Do not double up.

Can I Stay on a Lower Dose Long-Term?

Absolutely. If 7.5 mg or 10 mg is giving you the results you want with tolerable side effects, there's no requirement to push to 15 mg. In my practice, I see many patients who maintain excellent outcomes at middle-range doses for years.

Frequently Asked Questions

What is the standard tirzepatide dosage chart for weight loss?

Tirzepatide starts at 2.5 mg weekly and increases by 2.5 mg every 4 weeks. The available doses are 2.5, 5, 7.5, 10, 12.5, and 15 mg. Most weight loss patients settle at 10–15 mg for maintenance, though some achieve their goals at lower doses.

How long does it take to reach the maximum tirzepatide dose?

Following the standard escalation schedule, it takes a minimum of 20 weeks (about 5 months) to reach 15 mg. Your prescriber may extend this timeline if you experience side effects that warrant slower titration.

Is the tirzepatide dosing schedule the same for Mounjaro and Zepbound?

Yes. Mounjaro (for type 2 diabetes) and Zepbound (for weight management) use the identical escalation schedule and dose options. The molecule is the same — only the indication and insurance coverage differ.

What's the most effective tirzepatide dose for weight loss?

The highest approved dose (15 mg) produced the most weight loss in clinical trials — about 20.9% of body weight at 72 weeks. However, 10 mg produced 19.5%, meaning the incremental benefit of higher doses is modest. The "most effective" dose for any individual is the one that produces satisfactory results with acceptable side effects.

Can my doctor adjust the tirzepatide dosage schedule?

Yes. The 4-week intervals are minimums, not mandates. If you're experiencing significant GI side effects, your physician can extend any dose step to 6–8 weeks. This doesn't compromise long-term outcomes — it actually improves adherence, which is the most important predictor of success.